Get the Stockscreener App
30.54
0.75%
-0.23
After Hours:
29.70
-0.84
-2.75%
Xenon Pharmaceuticals Inc stock is traded at $30.54, with a volume of 680.36K.
It is down -0.75% in the last 24 hours and down -2.43% over the past month.
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.
See More
Previous Close:
$30.77
Open:
$30.32
24h Volume:
680.36K
Relative Volume:
0.56
Market Cap:
$2.34B
Revenue:
$13.17M
Net Income/Loss:
$-199.06M
P/E Ratio:
-11.15
EPS:
-2.74
Net Cash Flow:
$-156.53M
1W Performance:
-1.52%
1M Performance:
-2.43%
6M Performance:
-23.61%
1Y Performance:
-29.19%
1-Day Range:
$30.28
$31.30
1-Week Range:
$30.00
$31.87
52-Week Range:
$26.74
$46.00
Xenon Pharmaceuticals Inc Stock (XENE) Company Profile
Name
Xenon Pharmaceuticals Inc
Sector
Industry
Phone
(604) 484-3300
Address
200 - 3650 GILMORE WAY, BURNABY
Compare XENE with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
XENE
Xenon Pharmaceuticals Inc
|
30.54 | 2.36B | 13.17M | -199.06M | -156.53M | -2.74 |
|
VRTX
Vertex Pharmaceuticals Inc
|
456.87 | 120.48B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
545.46 | 59.88B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
392.24 | 44.31B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
670.33 | 36.65B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
301.13 | 32.46B | 3.81B | -644.79M | -669.77M | -6.24 |
Xenon Pharmaceuticals Inc Stock (XENE) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-07-25 | Initiated | Chardan Capital Markets | Buy |
| Feb-11-25 | Initiated | Deutsche Bank | Buy |
| Oct-10-24 | Resumed | Raymond James | Outperform |
| Oct-01-24 | Initiated | H.C. Wainwright | Buy |
| Jan-04-24 | Initiated | Citigroup | Buy |
| Dec-08-23 | Initiated | Robert W. Baird | Outperform |
| Oct-24-23 | Resumed | Cantor Fitzgerald | Overweight |
| Apr-25-23 | Initiated | Cantor Fitzgerald | Overweight |
| Dec-14-22 | Initiated | Goldman | Buy |
| Dec-12-22 | Initiated | Cowen | Outperform |
| Nov-28-22 | Initiated | Wells Fargo | Overweight |
| Oct-19-22 | Initiated | Raymond James | Outperform |
| Aug-29-22 | Initiated | BofA Securities | Buy |
| Jul-21-22 | Initiated | JP Morgan | Overweight |
| Oct-28-21 | Initiated | RBC Capital Mkts | Outperform |
| Oct-02-20 | Initiated | SVB Leerink | Outperform |
| Jul-21-20 | Initiated | Needham | Buy |
| Jun-01-20 | Resumed | Jefferies | Buy |
| Mar-25-20 | Initiated | Wedbush | Outperform |
| Jan-08-20 | Initiated | William Blair | Outperform |
| Sep-20-19 | Initiated | Guggenheim | Buy |
| Aug-08-18 | Reiterated | Stifel | Buy |
| Mar-13-17 | Initiated | Jefferies | Buy |
| Oct-21-16 | Initiated | Stifel | Buy |
| Sep-26-16 | Initiated | Guggenheim | Buy |
| Apr-14-16 | Reiterated | Jefferies | Buy |
| Oct-30-15 | Resumed | Jefferies | Buy |
| Dec-02-14 | Initiated | Canaccord Genuity | Buy |
View All
Xenon Pharmaceuticals Inc Stock (XENE) Latest News
Using economic indicators to assess Xenon Pharmaceuticals Inc. potentialBuy and Exit Strategy Based on Momentum - Newser
Why Xenon Pharmaceuticals Inc. stock attracts strong analyst attentionTrend Confirmation Scanner with Entry Focus - Newser
What is the dividend policy of Xenon Pharmaceuticals Inc. stockTop Growth Entry Points For Every Investor - jammulinksnews.com
Is Xenon Pharmaceuticals Inc. still worth holding after the dipOversold Stock Bounce Playbook Generator - Newser
Xenon Pharmaceuticals Inc. stock trend forecastReal-Time Investment Picks with Accuracy - Newser
Is a relief rally coming for Xenon Pharmaceuticals Inc. holdersFundamental Forecast for Undervalued Stocks - Newser
Xenon Pharmaceuticals Inc. Company’s Quarterly Earnings Growth: What the Numbers SaySwing Gain Strategy with Entry Forecast - Newser
How Xenon Pharmaceuticals Inc. stock performs during market volatilityFree Breakout Momentum Picks With Protection - Newser
Identifying reversal signals in Xenon Pharmaceuticals Inc.Chart Risk Profile for Capital Preservation - Newser
Sector ETF performance correlation with Xenon Pharmaceuticals Inc.Free Trade Insight With Community Collaboration - Newser
Skandinaviska Enskilda Banken AB publ Acquires 7,081 Shares of Xenon Pharmaceuticals Inc. (NASDAQ:XENE) - Defense World
Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Shares Sold by Fiera Capital Corp - Defense World
Visual analytics tools that track Xenon Pharmaceuticals Inc. performanceBollinger Band Squeeze and Expansion Analysis - Newser
Should I buy Xenon Pharmaceuticals Inc. stock before earningsFree Breakout Entry Signal Confirmation Tool - Newser
What technical models suggest about Xenon Pharmaceuticals Inc.’s comebackStock Portfolio Risk and Return Analysis - Newser
Has Xenon Pharmaceuticals Inc. found a price floorStrategy Chart for Real-Time Trade Flow - Newser
Xenon Pharmaceuticals Inc. Recovery Gathers Momentum on Chart SignalsTrend Analysis for Safer Trades Gains Popularity - metal.it
Published on: 2025-07-29 06:12:13 - metal.it
What institutional investors are buying Xenon Pharmaceuticals Inc. stockExpert Picks Outlook To Watch Now - jammulinksnews.com
Published on: 2025-07-28 17:14:14 - metal.it
Why is Xenon Pharmaceuticals Inc. stock attracting strong analyst attentionMaximize gains with timely market signals - jammulinksnews.com
What are Xenon Pharmaceuticals Inc. company’s key revenue driversBreakthrough profit margins - jammulinksnews.com
Can technical indicators confirm Xenon Pharmaceuticals Inc.’s reversalStock Market Trend and Pattern Analysis - Newser
Xenon Pharmaceuticals Inc. Stock Approaches Key Moving AverageFast Entry High Potential Stock Alerts Triggered - metal.it
Is Xenon Pharmaceuticals Inc. a growth stock or a value stockUnlock steady growth with low-risk stocks - jammulinksnews.com
How does Xenon Pharmaceuticals Inc. compare to its industry peersSuperior profit margins - jammulinksnews.com
What are the latest earnings results for Xenon Pharmaceuticals Inc.Capitalize on high-growth stocks early - jammulinksnews.com
Is Xenon Pharmaceuticals Inc. Stock a Good Fit for Conservative Investors10x Potential Stocks - metal.it
Moving Average Trends for Xenon Pharmaceuticals Inc. Stock: What They IndicateControlled Risk High Reward Plan - Newser
What drives Xenon Pharmaceuticals Inc. stock priceMassive wealth growth - PrintWeekIndia
Xenon Pharmaceuticals Inc. Stock Analysis and ForecastExceptional ROI - PrintWeekIndia
What analysts say about Xenon Pharmaceuticals Inc. stockExplosive trading opportunities - Autocar Professional
Investors Buy Large Volume of Put Options on Xenon Pharmaceuticals (NASDAQ:XENE) - Defense World
Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Shares Bought by Bank of New York Mellon Corp - Defense World
Is Xenon Pharmaceuticals Inc. a good long term investmentFree Stock Selection - jammulinksnews.com
Xenon Pharmaceuticals Inc Stock (XENE) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.43%
2.00%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):